Literature DB >> 30377724

Intraoperative Fluid Administration and Surgical Outcomes Following Pancreaticoduodenectomy: External Validation at a Tertiary Referral Center.

M Sandini1, C Fernández-Del Castillo1, C R Ferrone1, K J Ruscic2, M Eikermann2, A L Warshaw1, K D Lillemoe1, M Qadan3.   

Abstract

BACKGROUND: While intraoperative fluid overload is associated with higher complication rates following surgery, data for pancreaticoduodenectomy are scarce and heterogeneous. We evaluated multiple prior definitions of restrictive and liberal fluid regimens and analyzed whether these affected surgical outcomes at our tertiary referral center.
METHODS: Studies evaluating different intraoperative fluid regimens on outcomes after pancreatic resections were retrieved. After application of all prior definitions of restrictive and liberal fluid regimens to our patient cohort, relative risks of each outcome were calculated using all reported infusion regimens.
RESULTS: Five hundred and seven pancreaticoduodenectomies were included. Nine different fluid regimens were evaluated. Two regimens utilized absolute volume cutoffs, and the remaining evaluated various infusion rates, ranging from 5 to 15 mL/kg/h. Total volume administration of >5000 mL and >6000 mL was associated with increased complications (RR 1.25 and RR 1.17, respectively) and >6000 mL with increased sepsis (RR 2.14). Conversely, a rate of <5 mL/kg/h was associated with increased risk of postoperative pancreatic fistula (POPF, RR 3.16) and sepsis (RR 3.20), <6.8 mL/kg/h with increased major morbidity (RR 1.64) and sepsis (RR 2.27), and <8.2 mL/kg/h with increased POPF (RR 2.16). No effects were observed on pulmonary complications, surgical site infections, length of stay, or mortality.
CONCLUSIONS: In an uncontrolled setting with no standard intraoperative or postoperative care map, the volume of intraoperative fluid administration appears to have limited impact on early postoperative outcomes following pancreaticoduodenectomy, with adverse outcomes only seen at extreme values.

Entities:  

Mesh:

Year:  2019        PMID: 30377724     DOI: 10.1007/s00268-018-4842-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  6 in total

1.  Development and validation of risk prediction nomogram for pancreatic fistula and risk-stratified strategy for drainage management after pancreaticoduodenectomy.

Authors:  Jie Yin; Qicong Zhu; Kai Zhang; Wentao Gao; Junli Wu; Zipeng Lu; Kuirong Jiang; Yi Miao
Journal:  Gland Surg       Date:  2022-01

2.  Optimal Perioperative Fluid Therapy Associates with Fewer Complications After Pancreaticoduodenectomy.

Authors:  Piia Peltoniemi; Pertti Pere; Harri Mustonen; Hanna Seppänen
Journal:  J Gastrointest Surg       Date:  2022-09-21       Impact factor: 3.267

3.  Pancreatic fistula after pancreatoduodenectomy due to compression of the superior mesenteric vessels: a case report.

Authors:  Hanteng Yang; Yanxian Ren; Zeyuan Yu; Huinian Zhou; Shuze Zhang; Changjiang Luo; Zuoyi Jiao
Journal:  BMC Surg       Date:  2020-07-28       Impact factor: 2.102

Review 4.  [Perioperative fluid management in major abdominal surgery].

Authors:  M von der Forst; S Weiterer; M Dietrich; M Loos; C Lichtenstern; M A Weigand; B H Siegler
Journal:  Anaesthesist       Date:  2021-02       Impact factor: 1.041

5.  Unfavorable effect of high postoperative fluid balance on outcome of pancreaticoduodenectomy.

Authors:  Hyun-Jeong Jeon; Hyung-Jun Kwon; Yoon-Jin Hwang; Sang-Geol Kim
Journal:  Ann Surg Treat Res       Date:  2022-03-04       Impact factor: 1.859

6.  A Single-Center Retrospective Study of Selected Clinical Parameters and Intraoperative Fluid Management of Patients Undergoing Pancreatoduodenectomy.

Authors:  Patryk Zemła; Justyna Bajak; Bartosz Molasy; Łukasz Krzych; Sławomir Mrowiec; Katarzyna Kuśnierz
Journal:  Med Sci Monit       Date:  2022-04-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.